Bovine embryos are now routinely used in agricultural systems as a means of disseminating superior genetics worldwide, ultimately with the aim of feeding an ever-growing population. Further investigations, common for human IVF embryos, thus have priority to improve cattle IVF, as has screening for aneuploidy (abnormal chromosome number). Although the incidence and consequences of aneuploidy are well documented in human preimplantation embryos, they are less well known for the embryos of other animals. To address this, we assessed aneuploidy levels in thirty-one 2-cell bovine embryos derived from early- and late-cleaving zygotes. Contemporary approaches ( Whole Genome Amplification and next-generation sequencing) allowed aneuploidy assessment for all chromosomes in oocytes from donors aged 4-7 years. We also quantified mitochondrial DNA (mtDNA) levels in all blastomeres assessed, thereby testing the hypothesis that they are related to levels of aneuploidy. The overall incidence of aneuploidy in this cohort of bovine embryos was 41.1% and correlated significantly with the timing of cleavage (77.8% in late-cleaving vs. 31.8% in early-cleaving embryos). Moreover, based on mtDNA sequence read counts, we observed that the median mtDNA quantity is significantly lower in late-cleaving embryos. These findings further reinforce the use of the bovine system as a model for human IVF studies.

Keywords:
Aneuploidy, Cattle, Embryo, Mitochondria, Next-generation sequencing
1.
Aho AV, Kernighan BW, Weinberger PJ: The AWK Programming Language (Addison-Wesley Longman Publishing Co., Inc., Boston 1987).
2.
Alfarawati S, Fragouli E, Colls P, Stevens J, Gutiérrez-Mateo C, et al: The relationship between blastocyst morphology, chromosomal abnormality, and embryo gender. Fertil Steril 95:520-524 (2011).
3.
Bazrgar M, Gourabi H, Yazdi PE, Vazirinasab H, Fakhri M, et al: DNA repair signalling pathway genes are overexpressed in poor-quality pre-implantation human embryos with complex aneuploidy. Eur J Obstet Gynecol Reprod Biol 175:152-156 (2014).
4.
Brevini T, Lonergan P, Cillo F, Francisci C, Favetta L, et al: Evolution of mRNA polyadenylation between oocyte maturation and first embryonic cleavage in cattle and its relation with developmental competence. Mol Reprod Dev 63:510-517 (2002).
5.
Chavez SL, Loewke KE, Han J, Moussavi F, Colls P, et al: Dynamic blastomere behaviour reflects human embryo ploidy by the four-cell stage. Nat Commun 3:1251 (2012).
6.
Chawla M, Fakih M, Shunnar A, Bayram A, Hellani A, et al: Morphokinetic analysis of cleavage stage embryos and its relationship to aneuploidy in a retrospective time-lapse imaging study. J Assist Reprod Genet 32:69-75 (2014).
7.
Coates A, Coate B, Holmes L, Griffin DK: Morphological and kinetic embryological criteria and correlation with aneuploidy rates: how might they be used to choose the best IVF embryo for transfer. Hum Genet Embryol 5:129 (2015).
8.
Coppola G, Alexander B, Di Berardino D, St John E, Basrur PK, King WA: Use of cross-species in-situ hybridization (ZOO-FISH) to assess chromosome abnormalities in day-6 in-vivo- or in-vitro-produced sheep embryos. Chromosome Res 15:399-408 (2007).
9.
Demyda-Peyrás S, Dorado J, Hidalgo M, Anter J, De Luca L, et al: Effects of oocyte quality, incubation time and maturation environment on the number of chromosomal abnormalities in IVF-derived early bovine embryos. Reprod Fertil Dev 25:1077-1084 (2013).
10.
Fiorentino F, Biricik A, Bono S, Spizzichino L, Cotroneo E, et al: Development and validation of a next-generation sequencing-based protocol for 24-chromosome aneuploidy screening of embryos. Fertil Steril 5:1375-1382 (2014).
11.
Fragouli E, Katz-Jaffe M, Alfarawati S, Stevens J, Colls P, et al: Comprehensive chromosome screening of polar bodies and blastocysts from couples experiencing repeated implantation failure. Fertil Steril 94:875-887 (2010).
12.
Fragouli E, Spath K, Alfarawati S, Kaper F, Craig A, et al: Altered levels of mitochondrial DNA are associated with female age, aneuploidy, and provide an independent measure of embryonic implantation potential. PLoS Genet 11:e1005241 (2015).
13.
Gabriel AS, Thornhill AR, Ottolini CS, Gordon A, Brown APC, et al: Array comparative genomic hybridisation on first polar bodies suggests that non-disjunction is not the predominant mechanism leading to aneuploidy in humans. J Med Genet 48:433-437 (2011).
14.
Garcia-Herreros M, Carter TF, Villagómez DAF, MacAulay AD, Rath D, et al: Incidence of chromosomal abnormalities in bovine blastocysts derived from unsorted and sex-sorted spermatozoa. Reprod Fertil Dev 22:1272-1278 (2010).
15.
Hassold T, Hall H, Hunt P: The origin of human aneuploidy: where we have been, where we are going. Hum Mol Genet 16 Spec No. 2:R203-R208 (2007).
16.
Hellani A, Abu-Amero K, Azouri J, El-Akoum S: Successful pregnancies after application of array-comparative genomic hybridization in PGS-aneuploidy screening. Reprod Biomed Online 17:841-847 (2008).
17.
Hornak M, Hulinska P, Musilova P, Kubickova S, Rubes J: Investigation of chromosome aneuploidies in early porcine embryos using comparative genomic hybridization. Cytogenet Genome Res 126:210-216 (2009).
18.
Hornak M, Oracova E, Hulinska P, Urbankova L, Rubes J: Aneuploidy detection in pigs using comparative genomic hybridization: from the oocytes to blastocysts. PLoS One 7:e30335 (2012).
19.
Hornak M, Jeseta M, Hanulakova S, Rubes J: A high incidence of chromosome abnormalities in two-cell stage porcine IVP embryos. J Appl Genet 56:515-523 (2015).
20.
Isom SC, Li RF, Whitworth KM, Prather RS: Timing of first embryonic cleavage is a positive indicator of the in vitro developmental potential of porcine embryos derived from in vitro fertilization, somatic cell nuclear transfer and parthenogenesis. Mol Reprod Dev 79:197-207 (2012).
21.
Jakobsen AS, Thomsen PD, Avery B: Few polyploid blastomeres in morphologically superior bovine embryos produced in vitro. Theriogenology 65:870-881 (2006).
22.
Johnson MT, Freeman EA, Gardner DK, Hunt PA: Oxidative metabolism of pyruvate is required for meiotic maturation of murine oocytes in vivo. Biol Reprod 77:2-8 (2007).
23.
Kawarsky SJ, Basrur PK, Stubbings RB, Hansen PJ, King WA: Chromosomal abnormalities in bovine embryos and their influence on development. Biol Reprod 54:53-59 (1996).
24.
King WA: Chromosome variation in the embryos of domestic animals. Cytogenet Genome Res 120:81-90 (2008).
25.
King WA, Guay P, Picard L: A cytogenetical study of 7-day-old bovine embryos of poor morphological quality. Genome 29:160-164 (1987).
26.
Lechniak D, Warzych E, Pers-Kamczyc E, Sosnowski J, Antosik P, Rubes J: Gilts and sows produce similar rate of diploid oocytes in vitro whereas the incidence of aneuploidy differs significantly. Theriogenology 68:755-762 (2007).
27.
Lechniak D, Pers-Kamczyc E, Pawlak P: Timing of the first zygotic cleavage as a marker of developmental potential of mammalian embryos. Reprod Biol 8:23-42 (2008).
28.
Li H, Durbin R: Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26:589-595 (2010).
29.
Lonergan P, Khatir H, Piumi F, Rieger D, Humblot P, Boland MP: Effect of time interval from insemination to first cleavage on the developmental characteristics, sex ratio and pregnancy rate after transfer of bovine embryos. J Reprod Fertil 117:159-167 (1999).
30.
Lonergan P, Gutiérrez-Adán A, Pintado B, Fair T, Ward F, et al: Relationship between time of first cleavage and the expression of IGF-I growth factor, its receptor, and two housekeeping genes in bovine two-cell embryos and blastocysts produced in vitro. Mol Reprod Dev 57:146-152 (2000).
31.
Lundin K, Bergh C, Hardarson T: Early embryo cleavage is a strong indicator of embryo quality in human IVF. Hum Reprod 16:2652-2657 (2001).
32.
Mantzouratou A, Delhanty JDA: Aneuploidy in the human cleavage stage embryo. Cytogenet Genome Res 133:141-148 (2011).
33.
Michaels GS, Hauswirth WW, Laipis PJ: Mitochondrial DNA copy number in bovine oocytes and somatic cells. Dev Biol 94:246-251 (1982).
34.
Munné S, Chen S, Colls P, Garrisi J, Zheng X, et al: Maternal age, morphology, development and chromosome abnormalities in over 6000 cleavage-stage embryos. Reprod Biomed Online 14:628-634 (2007).
35.
Nicodemo D, Pauciullo A, Cosenza G, Peretti V, Perucatti A, et al: Frequency of aneuploidy in in vitro-matured MII oocytes and corresponding first polar bodies in two dairy cattle (Bos taurus) breeds as determined by dual-color fluorescent in situ hybridization. Theriogenology 73:523-529 (2010).
36.
Ogino M, Tsubamoto H, Sakata K, Oohama N, Hayakawa H, et al: Mitochondrial DNA copy number in cumulus cells is a strong predictor of obtaining good-quality embryos after IVF. J Assist Reprod Genet 33:367-371 (2016).
37.
Pawlak P, Chabowska A, Malyszka N, Lechniak D: Mitochondria and mitochondrial DNA in porcine oocytes and cumulus cells - a search for developmental competence marker. Mitochondrion 27:48-55 (2016).
38.
Rambags BPB, Krijtenburg PJ, van Drie HF, Lazzari G, Galli C, et al: Numerical chromosomal abnormalities in equine embryos produced in vivo and in vitro. Mol Reprod Dev 72:77-87 (2005).
39.
Reynier P, May-Panloup P, Chrétien M-F, Morgan CJ, Jean M, et al: Mitochondrial DNA content affects the fertilizability of human oocytes. Mol Hum Reprod 7:425-429 (2001).
40.
Santos TA, El Shourbagy S, St John JC: Mitochondrial content reflects oocyte variability and fertilization outcome. Fertil Steril 85:584-591 (2006).
41.
Shourbagy SHE, Spikings EC, Freitas M, St John JC: Mitochondria directly influence fertilisation outcome in the pig. Reproduction 131:233-245 (2006).
42.
Smith LC, Alcivar AA: Cytoplasmic inheritance and its effects on development and performance. J Reprod Fertil Suppl 48:31-43 (1993).
43.
St John JC, Facucho-Oliveira J, Jiang Y, Kelly R, Salah R: Mitochondrial DNA transmission, replication and inheritance: a journey from the gamete through the embryo and into offspring and embryonic stem cells. Hum Reprod Update 16:488-509 (2010).
44.
Stojkovic M, Machado SA, Stojkovic P, Zakhartchenko V, Hutzler P, et al: Mitochondrial distribution and adenosine triphosphate content of bovine oocytes before and after in vitro maturation: correlation with morphological criteria and developmental capacity after in vitro fertilization and culture. Biol Reprod 64:904-909 (2001).
45.
Ulloa Ullo CM, Yoshizawa M, Komoriya E, Mitsui A, Nagai T, Kikuchi K: The blastocyst production rate and incidence of chromosomal abnormalities by developmental stage in in vitro produced porcine embryos. J Reprod Dev 54:22-29 (2008).
46.
van Blerkom JV, Davis PW, Lee J: Fertilization and early embryology: ATP content of human oocytes and developmental potential and outcome after in-vitro fertilization and embryo transfer. Hum Reprod 10:415-424 (1995).
47.
Viuff D, Rickords L, Offenberg H, Hyttel P, Avery B, et al: A high proportion of bovine blastocysts produced in vitro are mixoploid. Biol Reprod 60:1273-1278 (1999).
48.
Vozdová M, Machatková M, Kubicková S, Zudová D, Jokesová E, Rubes J: Frequency of aneuploidy in pig oocytes matured in vitro and of the corresponding first polar bodies detected by fluorescent in situ hybridization. Theriogenology 56:771-776 (2001).
49.
Warburton D, Kinney A: Chromosomal differences in susceptibility to meiotic aneuploidy. Environ Mol Mutagen 28:237-247 (1996).
50.
Yang Z, Lin J, Zhang J, Fong WI, Li P, et al: Randomized comparison of next-generation sequencing and array comparative genomic hybridization for preimplantation genetic screening: a pilot study. BMC Med Genomics 8:30 (2015).
51.
Zhang X, Wu XQ, Lu S, Guo YL, Ma X: Deficit of mitochondria-derived ATP during oxidative stress impairs mouse MII oocyte spindles. Cell Res 16:841-850 (2006).
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.